ACM Biolabs
- Biotech or pharma, therapeutic R&D
ACM Biolabs is a clinical-stage biotech leveraging a thermostable polymer-lipid hybrid nanoparticle platform for targeted delivery of mRNA, immunomodulators, and small molecules. Lead programs include a TLR9 agonist in oncology (ongoing clinical studies) and a CEPI-backed thermostable mRNA vaccine platform.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}